Dr. Prathyush V

Dr. Prathyush V is a distinguished Medical Oncologist based in Bengaluru with over 13 years of dedicated clinical experience in cancer care and treatment. He holds a strong academic foundation with an MBBS degree, MD in Radiation Oncology, and a DNB from the National Board of Examinations, which equips him with comprehensive knowledge across medical and radiation oncology disciplines.

Dr. Prathyush V specializes in delivering evidence-based multidisciplinary cancer treatment, with particular expertise in chemotherapy services—including adjuvant, neoadjuvant, and palliative regimens for solid tumors. He is well-versed in modern molecular targeted therapies, immunotherapy with immune checkpoint inhibitors, and biomarker-driven treatment strategies. His clinical practice encompasses hormone therapy for breast and prostate cancers, allowing him to tailor personalized treatment plans based on individual patient biology and tumor characteristics.

Dr. Prathyush V has built a strong reputation treating international patients from the Gulf region, Africa, and South Asia who seek advanced oncology care in India. He is fluent in English, Hindi, and Kannada, facilitating clear communication with diverse patient populations. His patient-centric approach combines technical expertise with compassionate care, ensuring international patients feel supported throughout their cancer treatment journey.

Dr. Prathyush V practices at Apollo Hospitals, Bannerghatta Road, one of Bengaluru's leading tertiary care centers. Apollo Hospitals is renowned for its state-of-the-art oncology infrastructure, experienced multidisciplinary tumor boards, and comprehensive support services for international patients, including assistance with travel logistics and accommodation. The hospital's commitment to quality and safety makes it an ideal destination for cancer treatment.

International patients choosing Dr. Prathyush V at Apollo benefit from access to cutting-edge diagnostics, advanced chemotherapy protocols, and seamless coordination with surgical and radiation oncology teams—all within India's cost-effective healthcare framework.